Media coverage about Imperva (NASDAQ:IMPV) has been trending somewhat positive this week, according to Accern. Accern identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Imperva earned a news sentiment score of 0.15 on Accern’s scale. Accern also gave news stories about the software maker an impact score of 47.2442920650875 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Here are some of the media headlines that may have effected Accern’s rankings:
- Imperva (IMPV) Upgraded to “Overweight” by Piper Jaffray Companies (americanbankingnews.com)
- Evercore ISI Analysts Give Imperva (IMPV) a $56.00 Price Target (americanbankingnews.com)
- Imperva (IMPV) Price Target Increased to $55.00 by Analysts at Imperial Capital (americanbankingnews.com)
- Imperva (IMPV) Given New $39.00 Price Target at Morgan Stanley (americanbankingnews.com)
- Imperva beats 4Q profit forecasts (finance.yahoo.com)
IMPV has been the topic of a number of research analyst reports. Zacks Investment Research raised Imperva from a “hold” rating to a “strong-buy” rating and set a $50.00 target price on the stock in a report on Tuesday, October 24th. Morgan Stanley raised their target price on Imperva from $37.00 to $39.00 and gave the company an “underweight” rating in a report on Friday. Piper Jaffray Companies lowered Imperva from an “overweight” rating to a “neutral” rating and set a $42.00 target price on the stock. in a report on Monday, October 16th. Royal Bank of Canada reaffirmed a “buy” rating and issued a $49.00 target price on shares of Imperva in a report on Wednesday, October 18th. Finally, BidaskClub raised Imperva from a “hold” rating to a “buy” rating in a report on Wednesday. Three research analysts have rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $52.93.
Imperva (NASDAQ:IMPV) last announced its quarterly earnings data on Thursday, February 8th. The software maker reported $0.40 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.27 by $0.13. Imperva had a negative return on equity of 3.37% and a net margin of 7.11%. The company had revenue of $91.10 million for the quarter, compared to analyst estimates of $91.11 million. During the same quarter last year, the firm earned $0.32 EPS. Imperva’s revenue for the quarter was up 16.2% compared to the same quarter last year. sell-side analysts anticipate that Imperva will post -0.82 EPS for the current fiscal year.
WARNING: This article was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://stocknewstimes.com/2018/02/11/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-imperva-impv-share-price.html.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.